Options
Study protocol of the German Study on Tobacco Use (DEBRA): a national household survey of smoking behaviour and cessation
ISSN
1471-2458
Date Issued
2017
Author(s)
Kastaun, Sabrina
Brown, Jamie
Brose, Leonie S.
Ratschen, Elena
Nowak, Dennis
Cholmakow-Bodechtel, Constanze
Shahab, Lion
West, Robert
Kotz, Daniel
DOI
10.1186/s12889-017-4328-2
Abstract
Background: The prevalence of tobacco smoking in Germany is high (similar to 27%). Monitoring of national patterns of smoking behaviour and data on the "real-world" effectiveness of cessation methods are needed to inform policies and develop campaigns aimed at reducing tobacco-related harm. In England, the Smoking Toolkit Study (STS) has been tracking such indicators since 2006, resulting in the adaptation of tobacco control policies. However, findings cannot be directly transferred into the German health policy context. The German Study on Tobacco Use (DEBRA: "Deutsche Befragung zum Rauchverhalten") aims to provide such nationally representative data. Methods/Design: In June 2016, the study started collecting data from computer-assisted, face-to-face household interviews in people aged 14 years and older. Over a period of 3 years, a total of similar to 36,000 respondents will complete the survey with a new sample of similar to 2000 respondents every 2 months (=18 waves). This sample will report data on demographics and the use of tobacco and electronic (e-) cigarettes. Per wave, about 500-600 people are expected to be current or recent ex-smokers (<12 months since quitting). This sample will answer detailed questions about smoking behaviour, quit attempts, exposure to health professionals' advice on quitting, and use of cessation aids. Six-month follow-up data will be collected by telephone. Discussion: The DEBRA study will be an important source of data for tobacco control policies, health strategies, and future research. The methodology is closely aligned to the STS, which will allow comparisons with data from England, a country with one of the lowest smoking prevalence rates in Europe (18%).
File(s)
No Thumbnail Available
Name
12889_2017_Article_4328.pdf
Size
412.74 KB
Checksum (MD5)
3a4136c67ecbc126b366b2fda1754f18